Global markets for asthma and COPD drugs to hit $47.1 billion in 2017
According to the report ‘Global Markets for Asthma and COPD Drugs’ the global market for asthma and chronic obstructive pulmonary disease (COPD) prescription drugs was valued at $34.9 billion in 2011. This figure is forecast to hit $38 billion in 2012 and $47.1 billion in 2017, increasing at a five-year compound annual growth rate of 4.4%. The report states that Asthma and COPD are two diseases experiencing increasing prevalence globally due to a combination of factors, including a